Oded Kleifeld
Impact in
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms
- Oncology top 2%
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 22
- Signaling Pathways in Disease 6
- Oncology 27
- Peptidase Inhibition and Analysis 20
- Co-authors
- Christopher M. Overall (8 shared papers)Michael H. Glickman (18 shared papers)Jayachandran N. Kizhakkedathu (5 shared papers)Alain Doucet (4 shared papers)Ulrich auf dem Keller (2 shared papers)Anna Prudova (2 shared papers)Irit Sagi (9 shared papers)Noa Reis (10 shared papers)
- Journals
- Journal of Biological Chemistry (8 papers)Nature Communications (7 papers)Molecular & Cellular Proteomics (6 papers)Infection and Immunity (2 papers)Journal of Virology (2 papers)
- Partner nations
- IsraelAustraliaUnited States
In The Last Decade
Oded Kleifeld
79 papers receiving 4.5k citations
Oded Kleifeld's Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 1.0k
- Oncology 1.3k
- Immunology and Allergy 222
- Molecular Biology 2.6k
- Cell Biology 437
Countries citing papers authored by Oded Kleifeld
This map shows the geographic impact of Oded Kleifeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oded Kleifeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oded Kleifeld more than expected).
Fields of papers citing papers by Oded Kleifeld
This network shows the impact of papers produced by Oded Kleifeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oded Kleifeld. The network helps show where Oded Kleifeld may publish in the future.
Co-authors
The 25 scholars most cited alongside Oded Kleifeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy Hit paper breakdown → | 2006 | 1051 |
| 2 | 2010 | 456 | |
| 3 | 2011 | 258 | |
| 4 | 2014 | 150 | |
| 5 | 2021 | 135 | |
| 6 | 2014 | 125 | |
| 7 | 2011 | 117 | |
| 8 | 2018 | 116 | |
| 9 | 2015 | 111 | |
| 10 | 2003 | 110 | |
| 11 | 2009 | 109 | |
| 12 | 2014 | 102 | |
| 13 | 2021 | 97 | |
| 14 | 2002 | 85 | |
| 15 | 2008 | 77 | |
| 16 | 2001 | 65 | |
| 17 | 2018 | 62 | |
| 18 | 2018 | 55 | |
| 19 | 2016 | 51 | |
| 20 | 2018 | 50 |
About Oded Kleifeld
Oded Kleifeld is a scholar working on Molecular Biology, Oncology, Epidemiology, Genetics and Cell Biology, having authored 80 papers that have together received 4.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (22 papers), Peptidase Inhibition and Analysis (20 papers), Autophagy in Disease and Therapy (9 papers), Endoplasmic Reticulum Stress and Disease (7 papers), Protease and Inhibitor Mechanisms (7 papers), Signaling Pathways in Disease (6 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Advanced Proteomics Techniques and Applications (6 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.3k citations), Immunology and Allergy (222 citations), Molecular Biology (2.6k citations) and Cell Biology (437 citations). Oded Kleifeld has collaborated with scholars based in Israel, Australia and United States. Frequent co-authors include Christopher M. Overall, Michael H. Glickman, Jayachandran N. Kizhakkedathu, Alain Doucet, Ulrich auf dem Keller, Anna Prudova, Irit Sagi, Noa Reis, Anatoly I. Frenkel and Oliver Schilling. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications, Molecular & Cellular Proteomics, Infection and Immunity and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.